Acusphere Financial Statements From 2010 to 2025
Acusphere's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Acusphere's valuation are provided below:Acusphere does not presently have any fundamental signals for analysis.
This module can also supplement various Acusphere Technical models . Check out the analysis of Acusphere Correlation against competitors.
Check Acusphere financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acusphere's main balance sheet or income statement drivers, such as , as well as many indicators such as . Acusphere financial statements analysis is a perfect complement when working with Acusphere Valuation or Volatility modules.
Acusphere |
Acusphere Company Price To Sales Analysis
Acusphere's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Acusphere Price To Sales | 0.14 X |
Most of Acusphere's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acusphere is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Acusphere has a Price To Sales of 0.1383 times. This is 99.35% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 98.79% higher than that of the company.
Acusphere Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Acusphere's current stock value. Our valuation model uses many indicators to compare Acusphere value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acusphere competition to find correlations between indicators driving Acusphere's intrinsic value. More Info.Acusphere is number one stock in return on asset category among its peers. It is rated third in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Acusphere's earnings, one of the primary drivers of an investment's value.About Acusphere Financial Statements
Acusphere shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Acusphere investors may analyze each financial statement separately, they are all interrelated. The changes in Acusphere's assets and liabilities, for example, are also reflected in the revenues and expenses on on Acusphere's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts. ACUSPHERE INC is traded on PNK Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acusphere Pink Sheet Analysis
When running Acusphere's price analysis, check to measure Acusphere's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acusphere is operating at the current time. Most of Acusphere's value examination focuses on studying past and present price action to predict the probability of Acusphere's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acusphere's price. Additionally, you may evaluate how the addition of Acusphere to your portfolios can decrease your overall portfolio volatility.